Contact
searchSearch
HMP Global

COPD Topic Center

News
Comparative Effectiveness for Bronchodilator Responsiveness Testing
02/09/2024
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
Emphysema Can Be Detected During Lung Cancer Screenings
10/05/2023
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema...
10/05/2023
First Report Managed Care
Newsfeed
Intensive Care Patients Benefit From Antibiotics for COPD Exacerbations
12/14/2018
Antibiotics for acute exacerbations of COPD offer strong benefit for patients in the intensive care unit but just small effects for other inpatients as well as outpatients, according to a recent systematic review. 
Antibiotics for acute exacerbations of COPD offer strong benefit for patients in the intensive care unit but just small effects for other inpatients as well as outpatients, according to a recent systematic review. 
Antibiotics for acute...
12/14/2018
First Report Managed Care
Newsfeed
Disease Management Coaching Reduces Same-Day Admissions But Not Costs
12/11/2018
A population-based disease management program significantly reduced admissions for patients with COPD and diabetes but failed to significantly cut costs for higher-risk patients as a whole, according to results from a recent study.
A population-based disease management program significantly reduced admissions for patients with COPD and diabetes but failed to significantly cut costs for higher-risk patients as a whole, according to results from a recent study.
A population-based disease...
12/11/2018
First Report Managed Care
Newsfeed
Predicting Hospitalizations: Machine Learning Better Than Existing Algorithms for COPD
12/04/2018
Machine learning techniques applied to telemonitoring datasets are better than existing algorithms at predicting COPD exacerbations requiring hospitalization and decisions to start corticosteroids, researchers found.
Machine learning techniques applied to telemonitoring datasets are better than existing algorithms at predicting COPD exacerbations requiring hospitalization and decisions to start corticosteroids, researchers found.
Machine learning techniques...
12/04/2018
First Report Managed Care
News
Long-Term Benzodiazepine Use May Increase Suicide Risk Among Veterans
10/26/2018
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the...
10/26/2018
First Report Managed Care
News
Reduced Costs, Hospitalizations for COPD With Noninvasive Ventilation
10/17/2018
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic...
10/17/2018
First Report Managed Care
News
Discharge Care Bundle Reduces Readmissions for COPD
10/16/2018
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge...
10/16/2018
First Report Managed Care
News
Albuminuria Linked With COPD
10/11/2018
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers,...
10/11/2018
First Report Managed Care
News
Understanding COPD Seasonality Requires Big-Picture Approach
10/04/2018
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that...
10/04/2018
First Report Managed Care
News
First-in-Class Treatment Significantly Improves COPD Symptoms
09/28/2018
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed...
09/28/2018
First Report Managed Care

Newsfeed

News
Comparative Effectiveness for Bronchodilator Responsiveness Testing
02/09/2024
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
Emphysema Can Be Detected During Lung Cancer Screenings
10/05/2023
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema...
10/05/2023
First Report Managed Care
News
Long-Term Benzodiazepine Use May Increase Suicide Risk Among Veterans
10/26/2018
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the...
10/26/2018
First Report Managed Care
News
Reduced Costs, Hospitalizations for COPD With Noninvasive Ventilation
10/17/2018
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic...
10/17/2018
First Report Managed Care
News
Discharge Care Bundle Reduces Readmissions for COPD
10/16/2018
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge...
10/16/2018
First Report Managed Care
News
Albuminuria Linked With COPD
10/11/2018
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers,...
10/11/2018
First Report Managed Care
News
Understanding COPD Seasonality Requires Big-Picture Approach
10/04/2018
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that...
10/04/2018
First Report Managed Care
News
First-in-Class Treatment Significantly Improves COPD Symptoms
09/28/2018
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed...
09/28/2018
First Report Managed Care
News
Half of Heroin Smokers Screen Positive for COPD
09/28/2018
According to a recent study published online in CHEST, in people who smoked heroin and accessed screening services at community drug centers, about half had COPD or asthma-COPD overlap.
According to a recent study published online in CHEST, in people who smoked heroin and accessed screening services at community drug centers, about half had COPD or asthma-COPD overlap.
According to a recent study...
09/28/2018
First Report Managed Care
News
Recommended Changes for Next GOLD Guidelines Update
09/25/2018
Based on recent critiques of the current GOLD guidelines, a group of pulmonary clinicians and researchers from the Mayo Clinic have recommended several changes to the next major guideline update.
Based on recent critiques of the current GOLD guidelines, a group of pulmonary clinicians and researchers from the Mayo Clinic have recommended several changes to the next major guideline update.
Based on recent critiques of the...
09/25/2018
First Report Managed Care
News
Machine Learning Advances Revolutionize Pulmonary Arterial Hypertension Diagnosis
12/09/2024
Machine learning techniques such as combining machine learning with echocardiography and electrocardiography (ECG), show promising results in diagnosing pulmonary arterial hypertension (PAH), offering a potential noninvasive alternative to...
Machine learning techniques such as combining machine learning with echocardiography and electrocardiography (ECG), show promising results in diagnosing pulmonary arterial hypertension (PAH), offering a potential noninvasive alternative to...
Machine learning techniques such...
12/09/2024
First Report Managed Care
News
Immune-Related Adverse Events With ICIs Linked to Improved Survival in Metastatic NSCLC
12/09/2024
Developing a clinically meaningful immune-related adverse event (irAE) was associated with significantly improved overall survival in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) treated with immune...
Developing a clinically meaningful immune-related adverse event (irAE) was associated with significantly improved overall survival in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) treated with immune...
Developing a clinically...
12/09/2024
First Report Managed Care
News
Antiseizure Drugs for Tumor-Related Epilepsy Require Careful Management
12/04/2024
A recent consensus review discusses current management strategies for brain tumor-related epilepsy, with an emphasis on the role of antiseizure medications and surgical resection.
A recent consensus review discusses current management strategies for brain tumor-related epilepsy, with an emphasis on the role of antiseizure medications and surgical resection.
A recent consensus review...
12/04/2024
First Report Managed Care
News
Algorithm Predicts Seizure Control Outcomes After Brain Resection Surgery
12/03/2024
A machine learning algorithm predicted seizure control after temporal lobe resection using just 5 minutes of peri-ictal data from a scalp electroencephalogram (EEG) that is already part of the standard universal presurgical evaluation.
A machine learning algorithm predicted seizure control after temporal lobe resection using just 5 minutes of peri-ictal data from a scalp electroencephalogram (EEG) that is already part of the standard universal presurgical evaluation.
A machine learning algorithm...
12/03/2024
First Report Managed Care
News
Cognitive Dysfunction More Likely in Older Adults With Asthma
12/03/2024
Asthma was associated with cognitive dysfunction in a sample of adults aged 60 years and older from the National Health and Nutrition Examination Survey (NHANES).
Asthma was associated with cognitive dysfunction in a sample of adults aged 60 years and older from the National Health and Nutrition Examination Survey (NHANES).
Asthma was associated with...
12/03/2024
First Report Managed Care
News
Emicizumab as a Potential Treatment Pathway for Select Hemophilia B Cases
11/22/2024
New research highlights the potential of emicizumab, traditionally used to treat hemophilia A (HA), as a promising alternative therapy for certain hemophilia B (HB) genotypes.
New research highlights the potential of emicizumab, traditionally used to treat hemophilia A (HA), as a promising alternative therapy for certain hemophilia B (HB) genotypes.
New research highlights the...
11/22/2024
First Report Managed Care
News
Sex Differences in Survival Among Patients With Pulmonary Arterial Hypertension
11/22/2024
A recent study investigated the “sex paradox” in pulmonary arterial hypertension, which highlights better survival outcomes in women despite more severe disease presentation.
A recent study investigated the “sex paradox” in pulmonary arterial hypertension, which highlights better survival outcomes in women despite more severe disease presentation.
A recent study investigated the...
11/22/2024
First Report Managed Care
News
Patisiran Shows Promise in Treating Hereditary Transthyretin Amyloidosis With Polyneuropathy
11/22/2024
Patisiran offers promising benefits for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare and fatal genetic disorder characterized by amyloid fibril deposits affecting multiple organs.
Patisiran offers promising benefits for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare and fatal genetic disorder characterized by amyloid fibril deposits affecting multiple organs.
Patisiran offers promising...
11/22/2024
First Report Managed Care
News
Assessment of Individual Risk for Epilepsy After CVT Using the DIAS3 Score
11/20/2024
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and...
11/20/2024
First Report Managed Care
News
Using Deep Learning to Measure MS-Specific Brain Damage Beyond Aging
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care
FRMC Volume 21, Issue 4

Current Issue

October/November/December Volume 21, Issue 4, First Report Managed Care
Current Issue
Issue Archive

What's Trending?

News
FDA Expands Truvada PrEP for Use in Teen Patients
05/22/2018
The FDA recently approved a pre-exposure prophylaxis (PrEP) therapy for use in adolescent patients.
The FDA recently approved a pre-exposure prophylaxis (PrEP) therapy for use in adolescent patients.
The FDA recently approved a...
05/22/2018
First Report Managed Care
News
FDA approves new HIV diagnostic test
06/23/2010
06/23/2010
First Report Managed Care
Conference Insider
AMCP: Performance-based Risk-sharing Agreement Data Benefits Payers and Drug Makers
12/18/2015
  The development and launch of a new drug is filled with uncertainty. Historically, the pharmaceuti­cal manufacturer has no guarantee of success when investing in research and development, so, upon launch, it tends to seek the highest...
  The development and launch of a new drug is filled with uncertainty. Historically, the pharmaceuti­cal manufacturer has no guarantee of success when investing in research and development, so, upon launch, it tends to seek the highest...
  The development and launch of...
12/18/2015
First Report Managed Care
News
Whistleblower lawsuit accuses 3 drugmakers
09/14/2011
09/14/2011
First Report Managed Care
News
Pharma and Biotech on a Roll as Drug Approvals Hit 18-Year High
01/01/2015
U.S. drug approvals in 2014 hit their highest level in 18 years and recommendations in Europe also came at a rapid rate, driven by expensive new treatments for cancer and rare diseases.
U.S. drug approvals in 2014 hit their highest level in 18 years and recommendations in Europe also came at a rapid rate, driven by expensive new treatments for cancer and rare diseases.
U.S. drug approvals in 2014 hit...
01/01/2015
First Report Managed Care

Video Insights

Hennessy Headshot
Videos
Navigating Biosimilar Integration: Cost Savings, Coverage, and Future Strategies for Payers
12/10/2024
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses...
12/10/2024
First Report Managed Care
Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use